Chicago Trust’s Celgene Corp CELG Stock Holding History

Chicago Trust’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,956	Closed	-$226K	–	181
2015 Q2	$226K	Sell	1,956 -450	-19%	-$51.4K	0.08%	164
2015 Q1	$278K	Buy	+2,406	New	+$288K	0.1%	154

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Chicago Trust's CELG Position: Q3 2015 in Review

Chicago Trust sold out of Celgene Corp (CELG) in Q3 2015, closing a stake of 1,956 shares — an estimated $226K sold.

Chicago Trust first reported a position in CELG in Q1 2015 and held it in 2 quarters. The position peaked at $278K in Q1 2015. 1,195 funds tracked by Wall St. Rank hold CELG as of Q3 2015.

Chicago Trust reported no remaining Celgene Corp position as of Q3 2015 after selling out during the quarter.
Chicago Trust sold 1,956 Celgene Corp shares in Q3 2015, an estimated $226K.
Chicago Trust first reported a position in Celgene Corp in Q1 2015 and held it in 2 quarters.
Chicago Trust's Celgene Corp position peaked at $278K in Q1 2015.
1,195 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2015.

Based on Chicago Trust's 13F filing for Q3 2015, filed 14 Oct 2015.